Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study - Busca-Arenzana, C; Ortega-Gonzalez, D; Diaz-Almiron, M; Montes, M L; Martin-Carbonero, Luz; Mican, R; Montejano, R; Ramos-Ruperto, L; Valencia, Eulalia; Delgado-Hierro, Ana; Bernardino, Jose I (HIV MEDICINE, 2024)